REPORT HIGHLIGHT
Expression Vector Market size was valued at USD 453.2 Million in 2022, expanding at a CAGR of 5.2% from 2023 to 2030.
The expression of genes in an organism is facilitated using an expression vector, a form of vector used in molecular biology and genetic engineering. It is a DNA construct, such as a plasmid, that contains crucial components needed for transcription.
Expression Vector Market- Market Dynamics:
Growing demand biotechnology and pharmaceutical sector is expected to propel the expression vector demand.
The demand for novel treatments, vaccines, and diagnostic tools has been driving tremendous expansion in the biotechnology and pharmaceutical industries. Expression vectors are significant tools in these industries since they are necessary in the production of recombinant proteins and other biologics. The development of gene therapy and gene editing technologies has increased the demand for effective therapeutic gene delivery methods. Researchers can create potential remedies for genetic disorders and other diseases by using expression vectors as gene delivery vehicles to introduce functional genes into target cells and tissues.
Targeted therapy development has been sparked by the rising incidence of chronic diseases like cancer, diabetes, and autoimmune disorders. To produce the recombinant proteins and antibodies required in these therapeutic methods, expression vectors are essential. The development of vaccines and gene-based therapeutics depend on expression vectors, particularly viral vectors like adenovirus and lentivirus, which has increased demand for these vectors.
Expression Vector Market- Key Insights:
- As per the analysis shared by our research analyst, the global Expression Vector market is estimated to grow annually at a CAGR of around 5.2% over the forecast period (2023-2030)
- The Expression Vector industry is projected to grow at a significant rate due to the growing focus on construction.
- Based on Application, therapeutic segment was predicted to show maximum market share in the year 2022.
- Based on End User, pharmaceutical & biotech segment is expected to hold significant market share by 2030.
- Based on Host Type segmentation, bacterial expression vector segment was the leading in 2022
- On the basis of region, North America was the leading revenue generator in 2022.
Expression Vector Market- Segmentation Analysis:
The Global Expression Vector Market is segmented on the basis of Host Type, Application, End User, and Region.
The market is divided into five categories based on Host Type: bacterial expression vectors, mammalian expression vectors, insect expression vectors, yeast expression vector, and others. The structural segment dominates the market. Increasing demand from industrial, aerospace sector is contributing to market growth.
The market is divided into four categories based on Application: therapeutic, research, and others. The therapeutic segment dominates the market. Increasing demand from therapeutic applications is expected to boost the market growth.
The market is divided into three categories based on End User: pharmaceutical & biotech, academic research, and others. The medical disposables segment dominates the market. The rising demand for composites in aerospace & automotive industries is increasing the segment growth.
Expression Vector Market- Geographical Insights:
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Expression Vector Market- Competitive Landscape:
Owing to the rapid development in medical, and rising demand from pharmaceutical sector, which influence the expression vector market. Several companies promote their products, including corporate websites, and Applications, are used by businesses to sell their solutions & Applications. Composite manufacturers compete on various factors, such as composite pricing, performance, composite creation, and marketing. reputation, and availability. Some of the primary techniques, and strategies used by corporations to consolidate their reach and expand their market share include new product launches, R&D expenditure, developing its distribution network and mergers & acquisitions. Some of the recent developments are mentioned below.
Recent Developments:
In February 2021, Catalent acquired Delphi Genetics and opened a US plasmid manufacturing facility to establish global pDNA development facility.
Key features of the study:
- This proposed research study on Expression Vector market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the Expression Vector market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Expression Vector market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Expression Vector market
- Impact of COVID-19 on Expression Vector market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Expression Vector market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Expression Vector market, we have also included competitive landscape and key innovator analysis for the Expression Vector market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial inspection and strategic initiatives of players operating in the Expression Vector market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Expression Vector market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL EXPRESSION VECTOR MARKET KEY PLAYERS
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Promega Corporation
- Takara Bio Company
- Agilent Technologies, Inc.
- New England Biolabs, Inc.
- GenScript Biotech Corporation
- Bio-Rad Laboratories, Inc.
- Lonza Group Ltd.
- OriGene Technologies, Inc.
- Takara Bio Inc.
- Addgene, Inc.
- InvivoGen
- Vigene Biosciences, Inc.
- Mirus Bio LLC
GLOBAL EXPRESSION VECTOR MARKET, BY HOST TYPE
- Bacterial expression vectors
- Mammalian expression vectors
- Insect expression vectors
- Yeast expression vector
- Others
GLOBAL EXPRESSION VECTOR MARKET, BY APPLICATION
- Therapeutic
- Research
- Others
GLOBAL EXPRESSION VECTOR MARKET, BY END USER
- Pharmaceutical & biotech
- Academic research
- Others
GLOBAL EXPRESSION VECTOR MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA